Literature DB >> 24770491

Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharides.

Po-Hung Hsieh1, Yongmei Xu1, David A Keire2, Jian Liu3.   

Abstract

Heparan sulfate and heparin are highly sulfated polysaccharides that consist of a repeating disaccharide unit of glucosamine and glucuronic or iduronic acid. The 2-O-sulfated iduronic acid (IdoA2S) residue is commonly found in heparan sulfate and heparin; however, 2-O-sulfated glucuronic acid (GlcA2S) is a less abundant monosaccharide (∼<5% of total saccharides). Here, we report the synthesis of three GlcA2S-containing hexasaccharides using a chemoenzymatic approach. For comparison purposes, additional IdoA2S-containing hexasaccharides were synthesized. Nuclear magnetic resonance analyses were performed to obtain full chemical shift assignments for the GlcA2S- and IdoA2S-hexasaccharides. These data show that GlcA2S is a more structurally rigid saccharide residue than IdoA2S. The antithrombin (AT) binding affinities of a GlcA2S- and an IdoA2S-hexasaccharide were determined by affinity co-electrophoresis. In contrast to IdoA2S-hexasaccharides, the GlcA2S-hexasaccharide does not bind to AT, confirming that the presence of IdoA2S is critically important for the anticoagulant activity. The availability of pure synthetic GlcA2S-containing oligosaccharides will allow the investigation of the structure and activity relationships of individual sites in heparin or heparan sulfate.
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  chemoenzymatic synthesis; heparan sulfate; heparin; oligosaccharides; sulfotransferase

Mesh:

Substances:

Year:  2014        PMID: 24770491      PMCID: PMC4070978          DOI: 10.1093/glycob/cwu032

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  35 in total

1.  2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity.

Authors:  Robert J Linhardt
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

Review 2.  Chemical synthesis of heparin fragments and analogues.

Authors:  M Petitou; C A van Boeckel
Journal:  Fortschr Chem Org Naturst       Date:  1992

3.  Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2.

Authors:  J Kreuger; M Salmivirta; L Sturiale; G Giménez-Gallego; U Lindahl
Journal:  J Biol Chem       Date:  2001-06-13       Impact factor: 5.157

Review 4.  Structure and biological activity of heparin.

Authors:  B Casu
Journal:  Adv Carbohydr Chem Biochem       Date:  1985       Impact factor: 12.200

5.  Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns.

Authors:  Cynthia D Sommers; Hongping Ye; Richard E Kolinski; Moheb Nasr; Lucinda F Buhse; Ali Al-Hakim; David A Keire
Journal:  Anal Bioanal Chem       Date:  2011-09-07       Impact factor: 4.142

6.  Synthesis of conformationally locked L-iduronic acid derivatives: direct evidence for a critical role of the skew-boat 2S0 conformer in the activation of antithrombin by heparin.

Authors:  S K Das; J M Mallet; J Esnault; P A Driguez; P Duchaussoy; P Sizun; J P Herault; J M Herbert; M Petitou; P Sinaÿ
Journal:  Chemistry       Date:  2001-11-19       Impact factor: 5.236

7.  Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach.

Authors:  M K Lee; A D Lander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences.

Authors:  D R Ferro; A Provasoli; M Ragazzi; B Casu; G Torri; V Bossennec; B Perly; P Sinaÿ; M Petitou; J Choay
Journal:  Carbohydr Res       Date:  1990-01-15       Impact factor: 2.104

9.  Isolation of the porcine heparin tetrasaccharides with glucuronate 2-O-sulfate. Heparinase cleaves glucuronate 2-O-sulfate-containing disaccharides in highly sulfated blocks in heparin.

Authors:  S Yamada; T Murakami; H Tsuda; K Yoshida; K Sugahara
Journal:  J Biol Chem       Date:  1995-04-14       Impact factor: 5.157

10.  Molecular profiling and weight determination of heparins and depolymerized heparins.

Authors:  A Ahsan; W Jeske; D Hoppensteadt; J C Lormeau; H Wolf; J Fareed
Journal:  J Pharm Sci       Date:  1995-06       Impact factor: 3.534

View more
  10 in total

1.  Synthesis of 3-O-Sulfated Oligosaccharides to Understand the Relationship between Structures and Functions of Heparan Sulfate.

Authors:  Zhangjie Wang; Po-Hung Hsieh; Yongmei Xu; David Thieker; Evangeline Juan En Chai; Shaoshuai Xie; Brian Cooley; Robert J Woods; Lianli Chi; Jian Liu
Journal:  J Am Chem Soc       Date:  2017-04-03       Impact factor: 15.419

Review 2.  Synthetic Oligosaccharide Libraries and Microarray Technology: A Powerful Combination for the Success of Current Glycosaminoglycan Interactomics.

Authors:  Vitor H Pomin; Xu Wang
Journal:  ChemMedChem       Date:  2017-12-06       Impact factor: 3.466

3.  Synthetic oligosaccharides can replace animal-sourced low-molecular weight heparins.

Authors:  Yongmei Xu; Kasemsiri Chandarajoti; Xing Zhang; Vijayakanth Pagadala; Wenfang Dou; Debra Moorman Hoppensteadt; Erica M Sparkenbaugh; Brian Cooley; Sharon Daily; Nigel S Key; Diana Severynse-Stevens; Jawed Fareed; Robert J Linhardt; Rafal Pawlinski; Jian Liu
Journal:  Sci Transl Med       Date:  2017-09-06       Impact factor: 17.956

4.  Heparan Sulfate Microarray Reveals That Heparan Sulfate-Protein Binding Exhibits Different Ligand Requirements.

Authors:  Chengli Zong; Andre Venot; Xiuru Li; Weigang Lu; Wenyuan Xiao; Jo-Setti L Wilkes; Catherina L Salanga; Tracy M Handel; Lianchun Wang; Margreet A Wolfert; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2017-07-07       Impact factor: 15.419

5.  Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure.

Authors:  Katelyn Arnold; Yongmei Xu; Erica M Sparkenbaugh; Miaomiao Li; Xiaorui Han; Xing Zhang; Ke Xia; Mark Piegore; Fuming Zhang; Xiaoxiao Zhang; Mike Henderson; Vijayakanth Pagadala; Guowei Su; Lisi Tan; Pyong Woo Park; Richard T Stravitz; Nigel S Key; Robert J Linhardt; Rafal Pawlinski; Ding Xu; Jian Liu
Journal:  Sci Transl Med       Date:  2020-03-18       Impact factor: 17.956

6.  Uncovering the Relationship between Sulphation Patterns and Conformation of Iduronic Acid in Heparan Sulphate.

Authors:  Po-Hung Hsieh; David F Thieker; Marco Guerrini; Robert J Woods; Jian Liu
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

Review 7.  The Sea as a Rich Source of Structurally Unique Glycosaminoglycans and Mimetics.

Authors:  Ariana A Vasconcelos; Vitor H Pomin
Journal:  Microorganisms       Date:  2017-08-28

8.  Chemoenzymatic synthesis of heparan sulfate and heparin oligosaccharides and NMR analysis: paving the way to a diverse library for glycobiologists.

Authors:  Xing Zhang; Vijayakanth Pagadala; Hannah M Jester; Andrew M Lim; Truong Quang Pham; Anna Marie P Goulas; Jian Liu; Robert J Linhardt
Journal:  Chem Sci       Date:  2017-09-21       Impact factor: 9.825

9.  Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase.

Authors:  David F Thieker; Yongmei Xu; Digantkumar Chapla; Chelsea Nora; Hong Qiu; Thomas Felix; Lianchun Wang; Kelley W Moremen; Jian Liu; Jeffrey D Esko; Robert J Woods
Journal:  Sci Rep       Date:  2018-08-07       Impact factor: 4.379

10.  Synthesis of 3-O-Sulfated Heparan Sulfate Oligosaccharides Using 3-O-Sulfotransferase Isoform 4.

Authors:  Jine Li; Guowei Su; Yongmei Xu; Katelyn Arnold; Vijayakanth Pagadala; Chunyu Wang; Jian Liu
Journal:  ACS Chem Biol       Date:  2021-08-05       Impact factor: 4.634

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.